reference/15856547

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/15856547

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't\|Research Support, U.S. Gov't, P.H.S.
endingPage	268
issn	1521-0111 0026-895X
issueIdentifier	2
pageRange	263-268
publicationName	Molecular Pharmacology
startingPage	263
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c2de62851aee5825eefb200d2346ccd5 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_b69a7240ace55fc3a59b4a501deff081 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_4afe5bf880379b9896c81bc8c2140e2d http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_ac9332dab4dbcffc740ff8dfb133ddda
bibliographicCitation	Siegel D, Anwar A, Winski SL, Kepa JK, Zolman KL, Ross D. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1. Mol Pharmacol. 2001 Feb;59(2):263–8. doi: 10.1124/mol.59.2.263. PMID: 11160862.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd4887767b26c4a1ac4293f23b0e7b99 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9ed8ac7f4d91470b42df96a0f2045599 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-8307-5942 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b9e5fdfeb188f344f6896c630afc259 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6de3cbb00c4189c03ae7f52419a5c1f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_01e20323edb3317b8d6b7ef2028916e0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0fe4aafed932eab4e0f57f56cc1382a4
date	2001-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1124/mol.59.2.263 https://pubmed.ncbi.nlm.nih.gov/11160862
isPartOf	https://portal.issn.org/resource/ISSN/0026-895X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5912 https://portal.issn.org/resource/ISSN/1521-0111
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Rapid Polyubiquitination and Proteasomal Degradation of a Mutant Form of NAD(P)H:Quinone Oxidoreductase 1
discusses	http://id.nlm.nih.gov/mesh/M0002553 http://id.nlm.nih.gov/mesh/M0140424 http://id.nlm.nih.gov/mesh/M0123858 http://id.nlm.nih.gov/mesh/M0005542 http://id.nlm.nih.gov/mesh/M0022212 http://id.nlm.nih.gov/mesh/M0014188 http://id.nlm.nih.gov/mesh/M0018355
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D009097Q000378 http://id.nlm.nih.gov/mesh/D003546Q000378 http://id.nlm.nih.gov/mesh/D011808Q000378 http://id.nlm.nih.gov/mesh/D014452Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D019073 http://id.nlm.nih.gov/mesh/D011110 http://id.nlm.nih.gov/mesh/D018938 http://id.nlm.nih.gov/mesh/D011817 http://id.nlm.nih.gov/mesh/D001704Q000378 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D011808Q000235 http://id.nlm.nih.gov/mesh/D046988 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D009154
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.25.1 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5951 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_1.6.5.5 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5957 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4650 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID145742 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID462382

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128368395 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127481953 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129742316

Total number of triples: 62.